Pets at Home Group (PETS) Share Price, News & Analysis

Company Overview

We are the UK’s leading pet care business, providing pet owners with everything they need to be able to look after their pet – from food, toys and bedding, and grooming services, right the way through to first opinion veterinary care. Our stores represent a unique environment and provide a practical, fun and unique experience for pet owners. We’ll help owners select the right food for their pet with nutrition consultations, help test the water is safe for their fish tank before new fish are introduced, and help socialise a new puppy with socilaisation and training classes - and much more. We’re also online and our customers can order their pet products for home delivery or collect in store. Because we are a specialist pet care business everything we sell is tested specifically for pets, which is something we believe makes us unique, giving the customer peace of mind that they are buying a quality item which has been responsibly sourced and tested and is specific to an animal. When we sell a pet to a new owner we use our unique Pet Pad process which ensures a perspective owner understands the welfare needs of their pet to be, asking customers to sign to say they have understood how to look after their new family addition. Our in store and stand-alone veterinary practices provide full veterinary care from preventative healthcare including health checks and vaccinations right through to digital x ray and operating theatres.

Key Stats

• Today's Range: 241 to 247
• 50-Day Range: 242.80 to 273.20
• 52-Week Range: 193.90 to 319
• Volume: 617,352 shs
• Average Volume: 2.59 million shs
• Market Capitalization: £1.11 billion
• P/E Ratio: 14.76
• Dividend Yield: 5.35%
• Price Target: GBX 298.33
• Consensus Rating: Moderate Buy

PETS Stock Analysis - Frequently Asked Questions

How have PETS shares performed this year?

Pets at Home Group's stock was trading at GBX 205.60 on January 1st, 2025. Since then, PETS shares have increased by 18.1% and is now trading at GBX 242.80.

How were Pets at Home Group's earnings last quarter?

Pets at Home Group Plc (LON:PETS) issued its earnings results on Wednesday, May, 28th. The company reported $21.00 earnings per share for the quarter. Pets at Home Group had a trailing twelve-month return on equity of 8.05% and a net margin of 5.36%.
Read the conference call transcript.

Is Pets at Home Group buying back stock?

Pets at Home Group's board authorized a stock repurchase program on Monday, June 9th 2025, which permits the company to buy back 0 shares, according to EventVestor. This permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's leadership believes its stock is undervalued.

How do I buy shares of Pets at Home Group?

Shares of PETS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Pets at Home Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pets at Home Group investors own include Lloyds Banking Group (LLOY), Inchcape (INCH), Vodafone Group Public (VOD), Aviva (AV), BP (BP), Fevertree Drinks (FEVR) and Canopy Growth (CGC).

Company Calendar

• Last Earnings: 5/28/2025
• Today: 7/13/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Cyclical
• Industry: Specialty Retail
• Sub-Industry: Retail
• Current Symbol: LON:PETS
• CIK: N/A
• Web: www.petsathome.com
• Phone: +44-161-4866688
• Fax: N/A
• Employees: 210
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Pets at Home Group: GBX 298.33
• High Price Target: GBX 350
• Low Price Target: GBX 245
• Potential Upside/Downside: +22.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 16.45
• Trailing P/E Ratio: 14.76
• Forward P/E Ratio: 10.71
• P/E Growth: 2.66
• Net Income: £75.43 million
• Net Margins: 5.36%
• Pretax Margin: N/A
• Return on Equity: 8.05%
• Return on Assets: 4.66%

Debt

• Debt-to-Equity Ratio: 43.13
• Current Ratio: 0.63
• Quick Ratio: 0.57

Sales & Book Value

• Annual Sales: £1.41 billion
• Price / Sales: 0.79
• Cash Flow: GBX 25.98 per share
• Price / Cash Flow: 9.35
• Book Value: GBX 206.39 per share
• Price / Book: 1.18

Miscellaneous

• Outstanding Shares: 456,125,570
• Free Float: N/A
• Market Cap: £1.11 billion
• Optionable: Not Optionable
• Beta: 0.69